Welding and the risk of head and neck cancer: the ICARE study.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
05 2020
Historique:
received: 10 07 2019
revised: 14 12 2019
accepted: 21 12 2019
pubmed: 22 1 2020
medline: 25 6 2020
entrez: 22 1 2020
Statut: ppublish

Résumé

To investigate the association between occupational exposure to welding and the risk of head and neck cancer in a large French population-based case-control study, the Analyses were restricted to men (2703 controls and 1588 cases of squamous-cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx). Welding activity and potential confounders were assessed by detailed questionnaires. ORs and CIs (95% CI) were estimated by unconditional logistic regression, adjusted for age, area of residence, tobacco smoking, alcohol consumption and occupational exposure to asbestos. Welding was associated with an increased risk of head and neck cancer overall (OR=1.31, 95% CI 1.03 to 1.67). The association was strongest for laryngeal cancer (OR=1.66, 95% CI 1.15 to 2.38) and the risk increased with the cumulative duration (p-trend <0.01) and the weighted duration (p-trend <0.01) of welding. A cumulative duration and a weighted duration of welding of more than 10 years were also associated with a significantly increased risk of oral cancer (OR=1.82, 95% CI 1.09 to 3.04; OR=2.10, 95% CI 0.99 to 4.45, respectively). A long duration of arc welding was associated with laryngeal cancer, whereas a long duration of spot welding was associated with oral cancer. Welding was not associated with the risk of oropharyngeal and hypopharyngeal cancer. Our findings suggest that welding and several welding-related tasks increase the risk of laryngeal cancer and to a lesser extent oral cancer.

Identifiants

pubmed: 31959638
pii: oemed-2019-106080
doi: 10.1136/oemed-2019-106080
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-300

Investigateurs

Anne-Valérie Guizard (AV)
Arlette Danzon (A)
Anne-Sophie Woronoff (AS)
Michel Velten (M)
Antoine Buemi (A)
Émilie Marrer (É)
Brigitte Trétarre (B)
Marc Colonna (M)
Patricia Delafosse (P)
Paolo Bercelli (P)
Florence Molinié (F)
Simona Bara (S)
Bénédicte Lapotre-Ledoux (B)
Nicole Raverdy (N)
Sylvie Cénée (S)
Oumar Gaye (O)
Florence Guida (F)
Farida Lamkarkach (F)
Loredana Radoï (L)
Marie Sanchez (M)
Isabelle Stücker (I)
Matthieu Carton (M)
Diane Cyr (D)
Annie Schmaus (A)
Joëlle Févotte (J)
Corinne Pilorget (C)
Gwenn Menvielle (G)
Danièle Luce (D)

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Christine Barul (C)

Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.

Mireille Matrat (M)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM U1018, Cancer and Environment team, Villejuif, France.
Faculty of medicine, Paris Est Créteil University, Créteil, France.
Intercommunal hospital center, Service des Pathologies Professionnelles et de l'Environnement, Créteil, France.

Aviane Auguste (A)

Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.

Julien Dugas (J)

Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.

Loredana Radoï (L)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM U1018, Cancer and Environment team, Villejuif, France.
Faculty of Dental Surgery, University Paris Descartes, Paris, France.

Gwenn Menvielle (G)

Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique IPLESP, Department of social epidemiology, Paris, France.

Joëlle Févotte (J)

Fonds d'Indemnisation des Victimes de l'Amiante, Bagnolet, France.

Anne-Valérie Guizard (AV)

Registre Général des Tumeurs du Calvados, Centre François Baclesse, Caen, France.
ANTICIPE, Normandie Univ, Unicaen, INSERM, Centre François Baclesse, Caen, France.

Isabelle Stücker (I)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM U1018, Cancer and Environment team, Villejuif, France.

Danièle Luce (D)

Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France daniele.luce@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH